According to filings with the U.S. Securities and Exchange Commission, Ilant Health has raised $15,000,000.00 in new Series B funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

Investors in the company’s current round of funding include: Cornucopian Capital, naturalX, Peakbridge, Semcap AI, Evidenced, Operator Partners, Celtic, LifeX, AlphaLab.

About Ilant Health
Ilant Health is a specialized healthcare company that provides comprehensive, employer-backed metabolic and cardiometabolic care, with a core focus on obesity, diabetes, and heart health. It partners with employers and health plans to deliver a virtual, evidence-based medical program that combines lifestyle modification, FDA-approved medications (including GLP-1s and other anti-obesity drugs), and access to bariatric surgery when appropriate, all supported by transparent and predictable drug pricing. Ilants care model is built around a multidisciplinary team of board-certified obesity medicine physicians, licensed dietitians, mental health clinicians, and peer navigators, who use hundreds of individual data points such as connected device data, medical records, and labs to personalize treatment plans and manage high-cost interventions thoughtfully and effectively at scale. The company offers multiple programs, including Healthy Weight, Medical Weight Loss, Diabetes Management, and Cardiovascular Management, delivered entirely via virtual visits, app-based tools, and continuous remote support so members can regularly engage with their care team and track progress. Positioned as a single front door for individuals with obesity and metabolic risk, Ilant Health aims to improve outcomes such as average 15% weight loss after 12 months for members with obesity while helping employers and payers manage total cost of care through data-driven, value-based obesity and metabolic care solutions.

To learn more, visit https://www.ilanthealth.com/
Linkedin: https://www.linkedin.com/company/ilant-health/

Contact:
Elina Onitskansky, Chief Executive Officer
https://www.linkedin.com/in/elinaonitskansky/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.